Cargando…
Fatal postoperative systemic pulmonary hypertension in benfluorex-induced valvular heart disease surgery: A case report
RATIONALE: Drug-induced valvular heart disease (DI-VHD) remains an under-recognized entity. PATIENT CONCERNS: This report describes a heart valve replacement which was complicated by intractable systemic pulmonary arterial hypertension in a 61-year-old female with severe restrictive mitral and aorti...
Autores principales: | Baufreton, Christophe, Bruneval, Patrick, Rousselet, Marie-Christine, Ennezat, Pierre-Vladimir, Fouquet, Olivier, Giraud, Raphael, Banfi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266148/ https://www.ncbi.nlm.nih.gov/pubmed/28079786 http://dx.doi.org/10.1097/MD.0000000000004985 |
Ejemplares similares
-
Drug-Induced- or Rheumatic- Valvular Heart Disease in Patients Exposed to Benfluorex?
por: Le Ven, Florent, et al.
Publicado: (2016) -
Benfluorex and Unexplained Valvular Heart Disease: A Case-Control Study
por: Frachon, Irène, et al.
Publicado: (2010) -
Sub-aortic obstruction of left ventricular outflow tract secondary to benfluorex-induced endocardial fibrosis
por: Szymanski, Catherine, et al.
Publicado: (2015) -
Benfluorex withdrawal in France: Still be hiding somewhere in the world?
por: Frachon, Irène, et al.
Publicado: (2011) -
Echocardiographic Evidence for Valvular Toxicity of Benfluorex: A Double-Blind Randomised Trial in Patients with Type 2 Diabetes Mellitus
por: Derumeaux, Geneviève, et al.
Publicado: (2012)